Global Biologics Drug Development Market Research Report 2025(Status and Outlook)
Biologics drug development refers to the complex, multi-stage process of discovering, designing, manufacturing, and commercializing therapeutic agents derived from living organisms or their components?such as monoclonal antibodies, recombinant proteins, gene and cell therapies, vaccines, and blood products?distinguished from traditional small-molecule drugs by their large size, structural complexity, and production via biological systems. This process integrates advanced disciplines including molecular biology, genetic engineering, cell line development, upstream and downstream processing, rigorous analytical characterization, preclinical testing, and clinical trials, all governed by stringent regulatory frameworks to ensure safety, efficacy, and quality. The market encompasses a wide ecosystem of pharmaceutical companies, biotechnology firms, contract research and manufacturing organizations (CROs/CMOs), academic institutions, and regulatory bodies, driven by innovations in genomics, bioinformatics, and manufacturing technologies aimed at addressing unmet medical needs in areas such as oncology, immunology, and rare diseases.
The global Biologics Drug Development market size was estimated at USD 520.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biologics Drug Development market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biologics Drug Development market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biologics Drug Development market.
Global Biologics Drug Development Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market Segmentation (by Type)
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market Segmentation (by Application)
In-House
Outsource
Pharma Excess
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biologics Drug Development Market
Overview of the regional outlook of the Biologics Drug Development Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics Drug Development Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biologics Drug Development, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Biologics Drug Development market size was estimated at USD 520.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biologics Drug Development market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biologics Drug Development market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biologics Drug Development market.
Global Biologics Drug Development Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market Segmentation (by Type)
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market Segmentation (by Application)
In-House
Outsource
Pharma Excess
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biologics Drug Development Market
Overview of the regional outlook of the Biologics Drug Development Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics Drug Development Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biologics Drug Development, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biologics Drug Development
1.2 Key Market Segments
1.2.1 Biologics Drug Development Segment by Type
1.2.2 Biologics Drug Development Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS DRUG DEVELOPMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics Drug Development Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Biologics Drug Development Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS DRUG DEVELOPMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biologics Drug Development Product Life Cycle
3.3 Global Biologics Drug Development Sales by Manufacturers (2020-2025)
3.4 Global Biologics Drug Development Revenue Market Share by Manufacturers (2020-2025)
3.5 Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biologics Drug Development Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biologics Drug Development Market Competitive Situation and Trends
3.8.1 Biologics Drug Development Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biologics Drug Development Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS DRUG DEVELOPMENT INDUSTRY CHAIN ANALYSIS
4.1 Biologics Drug Development Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS DRUG DEVELOPMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biologics Drug Development Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biologics Drug Development Market
5.7 ESG Ratings of Leading Companies
6 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics Drug Development Sales Market Share by Type (2020-2025)
6.3 Global Biologics Drug Development Market Size Market Share by Type (2020-2025)
6.4 Global Biologics Drug Development Price by Type (2020-2025)
7 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics Drug Development Market Sales by Application (2020-2025)
7.3 Global Biologics Drug Development Market Size (M USD) by Application (2020-2025)
7.4 Global Biologics Drug Development Sales Growth Rate by Application (2020-2025)
8 BIOLOGICS DRUG DEVELOPMENT MARKET SALES BY REGION
8.1 Global Biologics Drug Development Sales by Region
8.1.1 Global Biologics Drug Development Sales by Region
8.1.2 Global Biologics Drug Development Sales Market Share by Region
8.2 Global Biologics Drug Development Market Size by Region
8.2.1 Global Biologics Drug Development Market Size by Region
8.2.2 Global Biologics Drug Development Market Size Market Share by Region
8.3 North America
8.3.1 North America Biologics Drug Development Sales by Country
8.3.2 North America Biologics Drug Development Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biologics Drug Development Sales by Country
8.4.2 Europe Biologics Drug Development Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biologics Drug Development Sales by Region
8.5.2 Asia Pacific Biologics Drug Development Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biologics Drug Development Sales by Country
8.6.2 South America Biologics Drug Development Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biologics Drug Development Sales by Region
8.7.2 Middle East and Africa Biologics Drug Development Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOLOGICS DRUG DEVELOPMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Biologics Drug Development by Region(2020-2025)
9.2 Global Biologics Drug Development Revenue Market Share by Region (2020-2025)
9.3 Global Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biologics Drug Development Production
9.4.1 North America Biologics Drug Development Production Growth Rate (2020-2025)
9.4.2 North America Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biologics Drug Development Production
9.5.1 Europe Biologics Drug Development Production Growth Rate (2020-2025)
9.5.2 Europe Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biologics Drug Development Production (2020-2025)
9.6.1 Japan Biologics Drug Development Production Growth Rate (2020-2025)
9.6.2 Japan Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biologics Drug Development Production (2020-2025)
9.7.1 China Biologics Drug Development Production Growth Rate (2020-2025)
9.7.2 China Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbvie
10.1.1 Abbvie Basic Information
10.1.2 Abbvie Biologics Drug Development Product Overview
10.1.3 Abbvie Biologics Drug Development Product Market Performance
10.1.4 Abbvie Business Overview
10.1.5 Abbvie SWOT Analysis
10.1.6 Abbvie Recent Developments
10.2 Allergan
10.2.1 Allergan Basic Information
10.2.2 Allergan Biologics Drug Development Product Overview
10.2.3 Allergan Biologics Drug Development Product Market Performance
10.2.4 Allergan Business Overview
10.2.5 Allergan SWOT Analysis
10.2.6 Allergan Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Basic Information
10.3.2 Boehringer Ingelheim Biologics Drug Development Product Overview
10.3.3 Boehringer Ingelheim Biologics Drug Development Product Market Performance
10.3.4 Boehringer Ingelheim Business Overview
10.3.5 Boehringer Ingelheim SWOT Analysis
10.3.6 Boehringer Ingelheim Recent Developments
10.4 Charles River Laboratories
10.4.1 Charles River Laboratories Basic Information
10.4.2 Charles River Laboratories Biologics Drug Development Product Overview
10.4.3 Charles River Laboratories Biologics Drug Development Product Market Performance
10.4.4 Charles River Laboratories Business Overview
10.4.5 Charles River Laboratories Recent Developments
10.5 Catalent
10.5.1 Catalent Basic Information
10.5.2 Catalent Biologics Drug Development Product Overview
10.5.3 Catalent Biologics Drug Development Product Market Performance
10.5.4 Catalent Business Overview
10.5.5 Catalent Recent Developments
10.6 Lonza Group
10.6.1 Lonza Group Basic Information
10.6.2 Lonza Group Biologics Drug Development Product Overview
10.6.3 Lonza Group Biologics Drug Development Product Market Performance
10.6.4 Lonza Group Business Overview
10.6.5 Lonza Group Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Biologics Drug Development Product Overview
10.7.3 Amgen Biologics Drug Development Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 Sanofi
10.8.1 Sanofi Basic Information
10.8.2 Sanofi Biologics Drug Development Product Overview
10.8.3 Sanofi Biologics Drug Development Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
11 BIOLOGICS DRUG DEVELOPMENT MARKET FORECAST BY REGION
11.1 Global Biologics Drug Development Market Size Forecast
11.2 Global Biologics Drug Development Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biologics Drug Development Market Size Forecast by Country
11.2.3 Asia Pacific Biologics Drug Development Market Size Forecast by Region
11.2.4 South America Biologics Drug Development Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biologics Drug Development by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Biologics Drug Development Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Biologics Drug Development by Type (2026-2033)
12.1.2 Global Biologics Drug Development Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Biologics Drug Development by Type (2026-2033)
12.2 Global Biologics Drug Development Market Forecast by Application (2026-2033)
12.2.1 Global Biologics Drug Development Sales (K Units) Forecast by Application
12.2.2 Global Biologics Drug Development Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biologics Drug Development
1.2 Key Market Segments
1.2.1 Biologics Drug Development Segment by Type
1.2.2 Biologics Drug Development Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS DRUG DEVELOPMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics Drug Development Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Biologics Drug Development Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS DRUG DEVELOPMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biologics Drug Development Product Life Cycle
3.3 Global Biologics Drug Development Sales by Manufacturers (2020-2025)
3.4 Global Biologics Drug Development Revenue Market Share by Manufacturers (2020-2025)
3.5 Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biologics Drug Development Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biologics Drug Development Market Competitive Situation and Trends
3.8.1 Biologics Drug Development Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biologics Drug Development Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS DRUG DEVELOPMENT INDUSTRY CHAIN ANALYSIS
4.1 Biologics Drug Development Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS DRUG DEVELOPMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biologics Drug Development Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biologics Drug Development Market
5.7 ESG Ratings of Leading Companies
6 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics Drug Development Sales Market Share by Type (2020-2025)
6.3 Global Biologics Drug Development Market Size Market Share by Type (2020-2025)
6.4 Global Biologics Drug Development Price by Type (2020-2025)
7 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics Drug Development Market Sales by Application (2020-2025)
7.3 Global Biologics Drug Development Market Size (M USD) by Application (2020-2025)
7.4 Global Biologics Drug Development Sales Growth Rate by Application (2020-2025)
8 BIOLOGICS DRUG DEVELOPMENT MARKET SALES BY REGION
8.1 Global Biologics Drug Development Sales by Region
8.1.1 Global Biologics Drug Development Sales by Region
8.1.2 Global Biologics Drug Development Sales Market Share by Region
8.2 Global Biologics Drug Development Market Size by Region
8.2.1 Global Biologics Drug Development Market Size by Region
8.2.2 Global Biologics Drug Development Market Size Market Share by Region
8.3 North America
8.3.1 North America Biologics Drug Development Sales by Country
8.3.2 North America Biologics Drug Development Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biologics Drug Development Sales by Country
8.4.2 Europe Biologics Drug Development Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biologics Drug Development Sales by Region
8.5.2 Asia Pacific Biologics Drug Development Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biologics Drug Development Sales by Country
8.6.2 South America Biologics Drug Development Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biologics Drug Development Sales by Region
8.7.2 Middle East and Africa Biologics Drug Development Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOLOGICS DRUG DEVELOPMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Biologics Drug Development by Region(2020-2025)
9.2 Global Biologics Drug Development Revenue Market Share by Region (2020-2025)
9.3 Global Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biologics Drug Development Production
9.4.1 North America Biologics Drug Development Production Growth Rate (2020-2025)
9.4.2 North America Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biologics Drug Development Production
9.5.1 Europe Biologics Drug Development Production Growth Rate (2020-2025)
9.5.2 Europe Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biologics Drug Development Production (2020-2025)
9.6.1 Japan Biologics Drug Development Production Growth Rate (2020-2025)
9.6.2 Japan Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biologics Drug Development Production (2020-2025)
9.7.1 China Biologics Drug Development Production Growth Rate (2020-2025)
9.7.2 China Biologics Drug Development Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbvie
10.1.1 Abbvie Basic Information
10.1.2 Abbvie Biologics Drug Development Product Overview
10.1.3 Abbvie Biologics Drug Development Product Market Performance
10.1.4 Abbvie Business Overview
10.1.5 Abbvie SWOT Analysis
10.1.6 Abbvie Recent Developments
10.2 Allergan
10.2.1 Allergan Basic Information
10.2.2 Allergan Biologics Drug Development Product Overview
10.2.3 Allergan Biologics Drug Development Product Market Performance
10.2.4 Allergan Business Overview
10.2.5 Allergan SWOT Analysis
10.2.6 Allergan Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Basic Information
10.3.2 Boehringer Ingelheim Biologics Drug Development Product Overview
10.3.3 Boehringer Ingelheim Biologics Drug Development Product Market Performance
10.3.4 Boehringer Ingelheim Business Overview
10.3.5 Boehringer Ingelheim SWOT Analysis
10.3.6 Boehringer Ingelheim Recent Developments
10.4 Charles River Laboratories
10.4.1 Charles River Laboratories Basic Information
10.4.2 Charles River Laboratories Biologics Drug Development Product Overview
10.4.3 Charles River Laboratories Biologics Drug Development Product Market Performance
10.4.4 Charles River Laboratories Business Overview
10.4.5 Charles River Laboratories Recent Developments
10.5 Catalent
10.5.1 Catalent Basic Information
10.5.2 Catalent Biologics Drug Development Product Overview
10.5.3 Catalent Biologics Drug Development Product Market Performance
10.5.4 Catalent Business Overview
10.5.5 Catalent Recent Developments
10.6 Lonza Group
10.6.1 Lonza Group Basic Information
10.6.2 Lonza Group Biologics Drug Development Product Overview
10.6.3 Lonza Group Biologics Drug Development Product Market Performance
10.6.4 Lonza Group Business Overview
10.6.5 Lonza Group Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Biologics Drug Development Product Overview
10.7.3 Amgen Biologics Drug Development Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 Sanofi
10.8.1 Sanofi Basic Information
10.8.2 Sanofi Biologics Drug Development Product Overview
10.8.3 Sanofi Biologics Drug Development Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
11 BIOLOGICS DRUG DEVELOPMENT MARKET FORECAST BY REGION
11.1 Global Biologics Drug Development Market Size Forecast
11.2 Global Biologics Drug Development Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biologics Drug Development Market Size Forecast by Country
11.2.3 Asia Pacific Biologics Drug Development Market Size Forecast by Region
11.2.4 South America Biologics Drug Development Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biologics Drug Development by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Biologics Drug Development Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Biologics Drug Development by Type (2026-2033)
12.1.2 Global Biologics Drug Development Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Biologics Drug Development by Type (2026-2033)
12.2 Global Biologics Drug Development Market Forecast by Application (2026-2033)
12.2.1 Global Biologics Drug Development Sales (K Units) Forecast by Application
12.2.2 Global Biologics Drug Development Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics Drug Development Market Size Comparison by Region (M USD)
Table 5. Global Biologics Drug Development Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Biologics Drug Development Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Biologics Drug Development Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Biologics Drug Development Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2024)
Table 10. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Biologics Drug Development Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Biologics Drug Development Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Biologics Drug Development Sales by Type (K Units)
Table 26. Global Biologics Drug Development Market Size by Type (M USD)
Table 27. Global Biologics Drug Development Sales (K Units) by Type (2020-2025)
Table 28. Global Biologics Drug Development Sales Market Share by Type (2020-2025)
Table 29. Global Biologics Drug Development Market Size (M USD) by Type (2020-2025)
Table 30. Global Biologics Drug Development Market Size Share by Type (2020-2025)
Table 31. Global Biologics Drug Development Price (USD/Unit) by Type (2020-2025)
Table 32. Global Biologics Drug Development Sales (K Units) by Application
Table 33. Global Biologics Drug Development Market Size by Application
Table 34. Global Biologics Drug Development Sales by Application (2020-2025) & (K Units)
Table 35. Global Biologics Drug Development Sales Market Share by Application (2020-2025)
Table 36. Global Biologics Drug Development Market Size by Application (2020-2025) & (M USD)
Table 37. Global Biologics Drug Development Market Share by Application (2020-2025)
Table 38. Global Biologics Drug Development Sales Growth Rate by Application (2020-2025)
Table 39. Global Biologics Drug Development Sales by Region (2020-2025) & (K Units)
Table 40. Global Biologics Drug Development Sales Market Share by Region (2020-2025)
Table 41. Global Biologics Drug Development Market Size by Region (2020-2025) & (M USD)
Table 42. Global Biologics Drug Development Market Size Market Share by Region (2020-2025)
Table 43. North America Biologics Drug Development Sales by Country (2020-2025) & (K Units)
Table 44. North America Biologics Drug Development Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Biologics Drug Development Sales by Country (2020-2025) & (K Units)
Table 46. Europe Biologics Drug Development Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Biologics Drug Development Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Biologics Drug Development Market Size by Region (2020-2025) & (M USD)
Table 49. South America Biologics Drug Development Sales by Country (2020-2025) & (K Units)
Table 50. South America Biologics Drug Development Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Biologics Drug Development Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Biologics Drug Development Market Size by Region (2020-2025) & (M USD)
Table 53. Global Biologics Drug Development Production (K Units) by Region(2020-2025)
Table 54. Global Biologics Drug Development Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Biologics Drug Development Revenue Market Share by Region (2020-2025)
Table 56. Global Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbvie Basic Information
Table 62. Abbvie Biologics Drug Development Product Overview
Table 63. Abbvie Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbvie Business Overview
Table 65. Abbvie SWOT Analysis
Table 66. Abbvie Recent Developments
Table 67. Allergan Basic Information
Table 68. Allergan Biologics Drug Development Product Overview
Table 69. Allergan Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Allergan Business Overview
Table 71. Allergan SWOT Analysis
Table 72. Allergan Recent Developments
Table 73. Boehringer Ingelheim Basic Information
Table 74. Boehringer Ingelheim Biologics Drug Development Product Overview
Table 75. Boehringer Ingelheim Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Business Overview
Table 77. Boehringer Ingelheim SWOT Analysis
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Charles River Laboratories Basic Information
Table 80. Charles River Laboratories Biologics Drug Development Product Overview
Table 81. Charles River Laboratories Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Charles River Laboratories Business Overview
Table 83. Charles River Laboratories Recent Developments
Table 84. Catalent Basic Information
Table 85. Catalent Biologics Drug Development Product Overview
Table 86. Catalent Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Catalent Business Overview
Table 88. Catalent Recent Developments
Table 89. Lonza Group Basic Information
Table 90. Lonza Group Biologics Drug Development Product Overview
Table 91. Lonza Group Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Lonza Group Business Overview
Table 93. Lonza Group Recent Developments
Table 94. Amgen Basic Information
Table 95. Amgen Biologics Drug Development Product Overview
Table 96. Amgen Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amgen Business Overview
Table 98. Amgen Recent Developments
Table 99. Sanofi Basic Information
Table 100. Sanofi Biologics Drug Development Product Overview
Table 101. Sanofi Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sanofi Business Overview
Table 103. Sanofi Recent Developments
Table 104. Global Biologics Drug Development Sales Forecast by Region (2026-2033) & (K Units)
Table 105. Global Biologics Drug Development Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. North America Biologics Drug Development Sales Forecast by Country (2026-2033) & (K Units)
Table 107. North America Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Europe Biologics Drug Development Sales Forecast by Country (2026-2033) & (K Units)
Table 109. Europe Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Asia Pacific Biologics Drug Development Sales Forecast by Region (2026-2033) & (K Units)
Table 111. Asia Pacific Biologics Drug Development Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Biologics Drug Development Sales Forecast by Country (2026-2033) & (K Units)
Table 113. South America Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Middle East and Africa Biologics Drug Development Sales Forecast by Country (2026-2033) & (Units)
Table 115. Middle East and Africa Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 116. Global Biologics Drug Development Sales Forecast by Type (2026-2033) & (K Units)
Table 117. Global Biologics Drug Development Market Size Forecast by Type (2026-2033) & (M USD)
Table 118. Global Biologics Drug Development Price Forecast by Type (2026-2033) & (USD/Unit)
Table 119. Global Biologics Drug Development Sales (K Units) Forecast by Application (2026-2033)
Table 120. Global Biologics Drug Development Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics Drug Development Market Size Comparison by Region (M USD)
Table 5. Global Biologics Drug Development Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Biologics Drug Development Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Biologics Drug Development Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Biologics Drug Development Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2024)
Table 10. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Biologics Drug Development Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Biologics Drug Development Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Biologics Drug Development Sales by Type (K Units)
Table 26. Global Biologics Drug Development Market Size by Type (M USD)
Table 27. Global Biologics Drug Development Sales (K Units) by Type (2020-2025)
Table 28. Global Biologics Drug Development Sales Market Share by Type (2020-2025)
Table 29. Global Biologics Drug Development Market Size (M USD) by Type (2020-2025)
Table 30. Global Biologics Drug Development Market Size Share by Type (2020-2025)
Table 31. Global Biologics Drug Development Price (USD/Unit) by Type (2020-2025)
Table 32. Global Biologics Drug Development Sales (K Units) by Application
Table 33. Global Biologics Drug Development Market Size by Application
Table 34. Global Biologics Drug Development Sales by Application (2020-2025) & (K Units)
Table 35. Global Biologics Drug Development Sales Market Share by Application (2020-2025)
Table 36. Global Biologics Drug Development Market Size by Application (2020-2025) & (M USD)
Table 37. Global Biologics Drug Development Market Share by Application (2020-2025)
Table 38. Global Biologics Drug Development Sales Growth Rate by Application (2020-2025)
Table 39. Global Biologics Drug Development Sales by Region (2020-2025) & (K Units)
Table 40. Global Biologics Drug Development Sales Market Share by Region (2020-2025)
Table 41. Global Biologics Drug Development Market Size by Region (2020-2025) & (M USD)
Table 42. Global Biologics Drug Development Market Size Market Share by Region (2020-2025)
Table 43. North America Biologics Drug Development Sales by Country (2020-2025) & (K Units)
Table 44. North America Biologics Drug Development Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Biologics Drug Development Sales by Country (2020-2025) & (K Units)
Table 46. Europe Biologics Drug Development Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Biologics Drug Development Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Biologics Drug Development Market Size by Region (2020-2025) & (M USD)
Table 49. South America Biologics Drug Development Sales by Country (2020-2025) & (K Units)
Table 50. South America Biologics Drug Development Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Biologics Drug Development Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Biologics Drug Development Market Size by Region (2020-2025) & (M USD)
Table 53. Global Biologics Drug Development Production (K Units) by Region(2020-2025)
Table 54. Global Biologics Drug Development Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Biologics Drug Development Revenue Market Share by Region (2020-2025)
Table 56. Global Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Biologics Drug Development Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbvie Basic Information
Table 62. Abbvie Biologics Drug Development Product Overview
Table 63. Abbvie Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbvie Business Overview
Table 65. Abbvie SWOT Analysis
Table 66. Abbvie Recent Developments
Table 67. Allergan Basic Information
Table 68. Allergan Biologics Drug Development Product Overview
Table 69. Allergan Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Allergan Business Overview
Table 71. Allergan SWOT Analysis
Table 72. Allergan Recent Developments
Table 73. Boehringer Ingelheim Basic Information
Table 74. Boehringer Ingelheim Biologics Drug Development Product Overview
Table 75. Boehringer Ingelheim Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Business Overview
Table 77. Boehringer Ingelheim SWOT Analysis
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Charles River Laboratories Basic Information
Table 80. Charles River Laboratories Biologics Drug Development Product Overview
Table 81. Charles River Laboratories Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Charles River Laboratories Business Overview
Table 83. Charles River Laboratories Recent Developments
Table 84. Catalent Basic Information
Table 85. Catalent Biologics Drug Development Product Overview
Table 86. Catalent Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Catalent Business Overview
Table 88. Catalent Recent Developments
Table 89. Lonza Group Basic Information
Table 90. Lonza Group Biologics Drug Development Product Overview
Table 91. Lonza Group Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Lonza Group Business Overview
Table 93. Lonza Group Recent Developments
Table 94. Amgen Basic Information
Table 95. Amgen Biologics Drug Development Product Overview
Table 96. Amgen Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amgen Business Overview
Table 98. Amgen Recent Developments
Table 99. Sanofi Basic Information
Table 100. Sanofi Biologics Drug Development Product Overview
Table 101. Sanofi Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sanofi Business Overview
Table 103. Sanofi Recent Developments
Table 104. Global Biologics Drug Development Sales Forecast by Region (2026-2033) & (K Units)
Table 105. Global Biologics Drug Development Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. North America Biologics Drug Development Sales Forecast by Country (2026-2033) & (K Units)
Table 107. North America Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Europe Biologics Drug Development Sales Forecast by Country (2026-2033) & (K Units)
Table 109. Europe Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Asia Pacific Biologics Drug Development Sales Forecast by Region (2026-2033) & (K Units)
Table 111. Asia Pacific Biologics Drug Development Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Biologics Drug Development Sales Forecast by Country (2026-2033) & (K Units)
Table 113. South America Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Middle East and Africa Biologics Drug Development Sales Forecast by Country (2026-2033) & (Units)
Table 115. Middle East and Africa Biologics Drug Development Market Size Forecast by Country (2026-2033) & (M USD)
Table 116. Global Biologics Drug Development Sales Forecast by Type (2026-2033) & (K Units)
Table 117. Global Biologics Drug Development Market Size Forecast by Type (2026-2033) & (M USD)
Table 118. Global Biologics Drug Development Price Forecast by Type (2026-2033) & (USD/Unit)
Table 119. Global Biologics Drug Development Sales (K Units) Forecast by Application (2026-2033)
Table 120. Global Biologics Drug Development Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biologics Drug Development
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics Drug Development Market Size (M USD), 2024-2033
Figure 5. Global Biologics Drug Development Market Size (M USD) (2020-2033)
Figure 6. Global Biologics Drug Development Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics Drug Development Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biologics Drug Development Product Life Cycle
Figure 13. Biologics Drug Development Sales Share by Manufacturers in 2024
Figure 14. Global Biologics Drug Development Revenue Share by Manufacturers in 2024
Figure 15. Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biologics Drug Development Revenue in 2024
Figure 18. Industry Chain Map of Biologics Drug Development
Figure 19. Global Biologics Drug Development Market PEST Analysis
Figure 20. Global Biologics Drug Development Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biologics Drug Development Market Share by Type
Figure 27. Sales Market Share of Biologics Drug Development by Type (2020-2025)
Figure 28. Sales Market Share of Biologics Drug Development by Type in 2024
Figure 29. Market Size Share of Biologics Drug Development by Type (2020-2025)
Figure 30. Market Size Share of Biologics Drug Development by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biologics Drug Development Market Share by Application
Figure 33. Global Biologics Drug Development Sales Market Share by Application (2020-2025)
Figure 34. Global Biologics Drug Development Sales Market Share by Application in 2024
Figure 35. Global Biologics Drug Development Market Share by Application (2020-2025)
Figure 36. Global Biologics Drug Development Market Share by Application in 2024
Figure 37. Global Biologics Drug Development Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biologics Drug Development Sales Market Share by Region (2020-2025)
Figure 39. Global Biologics Drug Development Market Size Market Share by Region (2020-2025)
Figure 40. North America Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Biologics Drug Development Sales Market Share by Country in 2024
Figure 43. North America Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biologics Drug Development Market Size Market Share by Country in 2024
Figure 45. U.S. Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biologics Drug Development Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Biologics Drug Development Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biologics Drug Development Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biologics Drug Development Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Biologics Drug Development Sales Market Share by Country in 2024
Figure 53. Europe Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biologics Drug Development Market Size Market Share by Country in 2024
Figure 55. Germany Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biologics Drug Development Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Biologics Drug Development Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biologics Drug Development Market Size Market Share by Region in 2024
Figure 68. China Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biologics Drug Development Sales and Growth Rate (K Units)
Figure 79. South America Biologics Drug Development Sales Market Share by Country in 2024
Figure 80. South America Biologics Drug Development Market Size and Growth Rate (M USD)
Figure 81. South America Biologics Drug Development Market Size Market Share by Country in 2024
Figure 82. Brazil Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biologics Drug Development Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Biologics Drug Development Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biologics Drug Development Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biologics Drug Development Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biologics Drug Development Production Market Share by Region (2020-2025)
Figure 103. North America Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 106. China Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Biologics Drug Development Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Biologics Drug Development Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Biologics Drug Development Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Biologics Drug Development Market Share Forecast by Type (2026-2033)
Figure 111. Global Biologics Drug Development Sales Forecast by Application (2026-2033)
Figure 112. Global Biologics Drug Development Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Biologics Drug Development
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics Drug Development Market Size (M USD), 2024-2033
Figure 5. Global Biologics Drug Development Market Size (M USD) (2020-2033)
Figure 6. Global Biologics Drug Development Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics Drug Development Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biologics Drug Development Product Life Cycle
Figure 13. Biologics Drug Development Sales Share by Manufacturers in 2024
Figure 14. Global Biologics Drug Development Revenue Share by Manufacturers in 2024
Figure 15. Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biologics Drug Development Revenue in 2024
Figure 18. Industry Chain Map of Biologics Drug Development
Figure 19. Global Biologics Drug Development Market PEST Analysis
Figure 20. Global Biologics Drug Development Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biologics Drug Development Market Share by Type
Figure 27. Sales Market Share of Biologics Drug Development by Type (2020-2025)
Figure 28. Sales Market Share of Biologics Drug Development by Type in 2024
Figure 29. Market Size Share of Biologics Drug Development by Type (2020-2025)
Figure 30. Market Size Share of Biologics Drug Development by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biologics Drug Development Market Share by Application
Figure 33. Global Biologics Drug Development Sales Market Share by Application (2020-2025)
Figure 34. Global Biologics Drug Development Sales Market Share by Application in 2024
Figure 35. Global Biologics Drug Development Market Share by Application (2020-2025)
Figure 36. Global Biologics Drug Development Market Share by Application in 2024
Figure 37. Global Biologics Drug Development Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biologics Drug Development Sales Market Share by Region (2020-2025)
Figure 39. Global Biologics Drug Development Market Size Market Share by Region (2020-2025)
Figure 40. North America Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Biologics Drug Development Sales Market Share by Country in 2024
Figure 43. North America Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biologics Drug Development Market Size Market Share by Country in 2024
Figure 45. U.S. Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biologics Drug Development Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Biologics Drug Development Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biologics Drug Development Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biologics Drug Development Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Biologics Drug Development Sales Market Share by Country in 2024
Figure 53. Europe Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biologics Drug Development Market Size Market Share by Country in 2024
Figure 55. Germany Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biologics Drug Development Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Biologics Drug Development Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biologics Drug Development Market Size Market Share by Region in 2024
Figure 68. China Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biologics Drug Development Sales and Growth Rate (K Units)
Figure 79. South America Biologics Drug Development Sales Market Share by Country in 2024
Figure 80. South America Biologics Drug Development Market Size and Growth Rate (M USD)
Figure 81. South America Biologics Drug Development Market Size Market Share by Country in 2024
Figure 82. Brazil Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biologics Drug Development Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Biologics Drug Development Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biologics Drug Development Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biologics Drug Development Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biologics Drug Development Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Biologics Drug Development Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biologics Drug Development Production Market Share by Region (2020-2025)
Figure 103. North America Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 106. China Biologics Drug Development Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Biologics Drug Development Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Biologics Drug Development Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Biologics Drug Development Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Biologics Drug Development Market Share Forecast by Type (2026-2033)
Figure 111. Global Biologics Drug Development Sales Forecast by Application (2026-2033)
Figure 112. Global Biologics Drug Development Market Share Forecast by Application (2026-2033)
